Literature DB >> 22301634

Age of infection and risk of virally associated cancers: new clues to an old puzzle.

Rachel Bagni, Denise Whitby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301634      PMCID: PMC3282569          DOI: 10.1093/infdis/jir871

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.

Authors:  G de-Thé; A Geser; N E Day; P M Tukei; E H Williams; D P Beri; P G Smith; A G Dean; G W Bronkamm; P Feorino; W Henle
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

2.  Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection.

Authors:  R J Biggar; W Henle; G Fleisher; J Böcker; E T Lennette; G Henle
Journal:  Int J Cancer       Date:  1978-09-15       Impact factor: 7.396

3.  Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.

Authors:  Erwan Piriou; Amolo S Asito; Peter O Sumba; Nancy Fiore; Jaap M Middeldorp; Ann M Moormann; Robert Ploutz-Snyder; Rosemary Rochford
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

4.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; Solange Solmeheim Soulanoudjingar; José Francisco Fernandes; Béatrice Peggy Abossolo; Cornelia Conzelmann; Barbara Gaelle Nfono Ondo Methogo; Yannick Doucka; Arnaud Flamen; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Arlindo Nhamuave; Diana Quelhas; Quique Bassat; Sofia Mandjate; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Omar Juma; Mwanajaa Shomari; Kafuruki Shubis; Francisca Machera; Ali Said Hamad; Rose Minja; Ali Mtoro; Alma Sykes; Saumu Ahmed; Alwisa Martin Urassa; Ali Mohammed Ali; Grace Mwangoka; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Marc Christian Tahita; William Kaboré; Sayouba Ouédraogo; Yara Sandrine; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Chris Odero; Martina Oneko; Kephas Otieno; Norbert Awino; Jackton Omoto; John Williamson; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Otsyula Nekoye; Stacey Gondi; Allan Otieno; Bernhards Ogutu; Ruth Wasuna; Victorine Owira; David Jones; Agnes Akoth Onyango; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Jesse Gitaka; Charity Maingi; Trudie Lang; Ally Olotu; Benjamin Tsofa; Philip Bejon; Norbert Peshu; Kevin Marsh; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; Samuel Ayamba; Kingsley Kayan; Ruth Owusu-Ofori; David Dosoo; Isaac Asante; George Adjei; George Adjei; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Hassan Kilavo; Coline Mahende; Edwin Liheluka; Martha Lemnge; Thor Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Alex Agyekum; Larko Owusu; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Ruthendo Nkomo; Albans Msika; Allan Jumbe; Nelecy Chome; Dalitso Nyakuipa; Joseph Chintedza; W Ripley Ballou; Myriam Bruls; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Johan Vekemans; Terrell Carter; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2011-10-18       Impact factor: 91.245

5.  Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses.

Authors:  Ann M Moormann; Kevin N Heller; Kiprotich Chelimo; Paula Embury; Robert Ploutz-Snyder; Juliana A Otieno; Margaret Oduor; Christian Münz; Rosemary Rochford
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

6.  Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.

Authors:  Lucy M Carpenter; Robert Newton; Delphine Casabonne; John Ziegler; Sam Mbulaiteye; Edward Mbidde; Henry Wabinga; Harold Jaffe; Valerie Beral
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

7.  Microgeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein-Barr virus.

Authors:  P O Sumba; E W Kabiru; E Namuyenga; N Fiore; R O Otieno; A M Moormann; A S Orago; P F Rosenbaum; R Rochford
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

8.  Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women.

Authors:  Alison M Elliott; Denise Whitby; Robert Newton; Katie Wakeham; Emily L Webb; Ismail Sebina; Lawrence Muhangi; Wendell Miley; W Thomas Johnson; Juliet Ndibazza
Journal:  Infect Agent Cancer       Date:  2011-09-30       Impact factor: 2.965

9.  African malaria control programs deliver ITNs and achieve what the clinical trials predicted.

Authors:  Thomas P Eisele; Richard W Steketee
Journal:  PLoS Med       Date:  2011-09-06       Impact factor: 11.069

10.  Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1997
  10 in total
  2 in total

1.  Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.

Authors:  Jennifer Beam Dowd; Tia Palermo; Jennifer Brite; Thomas W McDade; Allison Aiello
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

2.  Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence.

Authors:  Geng Xiong; Bo Zhang; Mu-yun Huang; Hufeng Zhou; Li-zhen Chen; Qi-sheng Feng; Xi Luo; Hui-jia Lin; Yi-xin Zeng
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.